Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AAMDC,Mth938 domain-containing protein,21934,25,2.12 [1.10-4.09],0.0251182521750046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,25691,26,1.80 [1.03-3.15],0.0396639540729159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,21807,24,3.42 [1.98-5.89],9.854844932341096e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABRAXAS2,BRISC complex subunit Abraxas 2,21807,24,1.80 [1.05-3.09],0.033743383537235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",25213,25,1.50 [1.06-2.14],0.0234958907304567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,25337,26,1.89 [1.16-3.09],0.0102595572178858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACHE,Acetylcholinesterase,22039,23,2.95 [1.18-7.37],0.0205270543759817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,21882,23,2.08 [1.18-3.68],0.0114156789867307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,25928,27,2.14 [1.26-3.63],0.0047446556585316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRBP,Acrosin-binding protein,22389,25,2.23 [1.10-4.51],0.0261856705107195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",25337,26,2.25 [1.54-3.28],2.7052212697314583e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,21807,24,1.95 [1.24-3.08],0.0039978762471905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,25601,25,15.57 [6.28-38.58],3.043837434143232e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,25813,27,1.83 [1.14-2.94],0.0124450876594884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,21807,24,2.08 [1.18-3.65],0.0109827127525357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,25645,26,5.10 [2.86-9.09],3.3767814326314376e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,21882,23,2.70 [1.74-4.21],1.0852442681137736e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,25992,26,6.89 [2.64-17.97],7.933318647623678e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22409,24,6.44 [3.55-11.67],8.610609761531834e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,21882,23,2.15 [1.05-4.41],0.0361825282216101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,25691,26,2.77 [1.47-5.20],0.0015390102598864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,21882,23,3.32 [1.59-6.94],0.0014139380698659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,25902,27,0.39 [0.19-0.79],0.008952803511454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,22510,25,9.30 [4.28-20.22],1.808084570025451e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADD1,Alpha-adducin,22039,23,1.77 [1.01-3.12],0.0471672618984967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,25601,25,2.91 [1.04-8.18],0.0426349884405328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,22039,23,5.66 [2.47-12.95],4.020234265080852e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,22409,24,2.30 [1.39-3.82],0.0012663230135003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,25944,25,5.65 [2.05-15.59],0.0008254670322876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,25997,26,4.30 [2.74-6.76],2.4535223938018244e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRF5,Adhesion G protein-coupled receptor F5,22521,25,3.85 [1.22-12.16],0.0218493736686836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,25691,26,2.47 [1.89-3.23],2.982358635579599e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,25813,27,0.58 [0.35-0.96],0.0355185569225396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADIPOQ,Adiponectin,22555,24,0.54 [0.31-0.96],0.0349320531301043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,26026,27,26.84 [6.41-112.44],6.774467283214127e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,24975,25,2.05 [1.58-2.66],6.269381585371107e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,25167,25,1.62 [1.00-2.63],0.0499828544552648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,25944,25,5.01 [2.43-10.33],1.241452996621213e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,26083,26,2.30 [1.35-3.94],0.002306030416919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,21934,25,3.16 [1.74-5.74],0.0001589304589076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK2,Protein AHNAK2,21934,25,4.47 [1.97-10.16],0.0003478446945189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B1,Aldo-keto reductase family 1 member B1,25213,25,1.67 [1.16-2.41],0.005648650638462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,21886,25,1.85 [1.33-2.59],0.0003151727078405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,26127,27,9.27 [2.20-39.00],0.002395869303751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",25736,24,1.41 [1.00-1.99],0.0481801196627428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,25991,27,17.86 [6.57-48.59],1.6462990427561125e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,25691,26,4.54 [1.03-19.98],0.0455360117062712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2A,Pancreatic alpha-amylase,24809,26,0.39 [0.19-0.80],0.0103976063680194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,25724,27,2.62 [1.16-5.93],0.0204239184958726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,26026,27,4.00 [1.87-8.56],0.0003617588865993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,25471,27,4.48 [1.46-13.76],0.008845524396614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL3,Angiopoietin-related protein 3,25808,27,0.34 [0.14-0.83],0.0176608538171925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,25901,25,4.18 [1.89-9.23],0.0004025254683789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,26026,27,3.58 [1.96-6.52],3.1117349607859474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA1,Annexin A1,21899,23,1.89 [1.02-3.48],0.0415919977914164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,25203,25,1.58 [1.15-2.19],0.0053487820315735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA2,Annexin A2,21589,25,1.51 [1.03-2.21],0.0338001337389397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA5,Annexin A5,25125,24,2.67 [1.11-6.38],0.027593402753785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,25899,27,6.49 [2.15-19.58],0.0009097429854862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP2B1,AP-2 complex subunit beta,21886,25,2.03 [1.21-3.42],0.0077843869178857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3B1,AP-3 complex subunit beta-1,22409,24,1.88 [1.17-3.01],0.0085371231176338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3S2,AP-3 complex subunit sigma-2,22469,25,2.31 [1.21-4.44],0.0117176736138992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,25691,26,1.79 [1.01-3.20],0.0478646694299989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,25813,27,0.43 [0.22-0.86],0.0167590518852121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA2,Apolipoprotein A-II,22523,24,2.59 [1.33-5.03],0.0051503023242203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,22555,24,3.23 [2.11-4.94],6.308612700851118e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,25854,27,0.48 [0.29-0.81],0.0058907229037552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,25691,26,3.41 [2.30-5.06],1.117455273113932e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,22479,24,1.73 [1.20-2.48],0.0032273330110417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,21797,24,1.74 [1.23-2.45],0.0016186680323429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART3,Ecto-ADP-ribosyltransferase 3,25899,27,4.12 [1.64-10.37],0.0026459794968019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,25641,25,13.82 [6.66-28.69],1.8034038532526096e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,22523,24,12.37 [5.07-30.19],3.306207237577856e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG16L1,Autophagy-related protein 16-1,22409,24,1.68 [1.06-2.66],0.0259690325427849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATOX1,Copper transport protein ATOX1,25902,27,1.79 [1.04-3.07],0.034697452009536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,21807,24,1.98 [1.21-3.24],0.0067383836682573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1F,V-type proton ATPase subunit F,25155,25,1.61 [1.01-2.58],0.0463154431580622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,22409,24,2.13 [1.65-2.74],5.436940262143655e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2L,Ataxin-2-like protein,22479,24,1.83 [1.06-3.13],0.0287133414745746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,25899,27,4.80 [1.81-12.75],0.0016509759808064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,22555,24,2.17 [1.70-2.76],3.8556254526862254e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",21934,25,7.58 [3.05-18.86],1.3138896452517052e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",25944,25,8.98 [3.38-23.85],1.046565319980716e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG4,BAG family molecular chaperone regulator 4,21882,23,1.96 [1.06-3.61],0.0306111176610469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,25213,25,1.88 [1.26-2.81],0.0020779186089878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,25213,25,3.49 [2.00-6.08],1.103525188477826e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,25641,25,0.60 [0.40-0.91],0.015237076401062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",22521,25,2.85 [1.14-7.13],0.02491948573998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2,Apoptosis regulator Bcl-2,22409,24,1.74 [1.18-2.57],0.0055037609876473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",25772,24,3.10 [1.19-8.03],0.0200847227632088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BECN1,Beclin-1,21934,25,1.90 [1.13-3.20],0.0161620818958813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIRC2,Baculoviral IAP repeat-containing protein 2,25213,25,1.77 [1.04-3.00],0.0357865418850145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP10,Bone morphogenetic protein 10,22039,23,4.39 [1.05-18.32],0.0423880811653766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,22039,23,1.76 [1.03-2.99],0.0372317765046956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,22521,25,2.14 [1.02-4.49],0.0432716966258021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,21882,23,2.70 [1.44-5.07],0.0019766732912727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA1,BolA-like protein 1,21797,24,1.91 [1.32-2.76],0.000600428783198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB1,BPI fold-containing family B member 1,25751,26,0.50 [0.32-0.79],0.0027921189997339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRK1,Protein BRICK1,25203,25,2.30 [1.15-4.59],0.0184861102152681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,26039,26,9.57 [2.21-41.48],0.0025335807890458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,25944,25,14.30 [5.85-34.92],5.242299681672806e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,25772,24,2.00 [1.25-3.19],0.0039495696755448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,25899,27,2.53 [1.50-4.26],0.0005161153414217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,25854,27,7.94 [1.96-32.14],0.0037031951376451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C5,Complement C5,22555,24,4.97 [1.23-20.11],0.0245825761720766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,22019,23,11.21 [4.27-29.46],9.45709792705663e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,25691,26,4.88 [3.20-7.44],1.537207911113632e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA3,Carbonic anhydrase 3,26079,27,2.42 [1.56-3.77],8.428800889512948e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA4,Carbonic anhydrase 4,26127,27,9.01 [2.79-29.04],0.000233184745102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",25337,26,1.61 [1.21-2.15],0.0011859751257234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,25730,26,0.45 [0.26-0.78],0.0045706032009779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB1,Calbindin,25691,26,2.19 [1.03-4.64],0.0406966863898912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB2,Calretinin,25203,25,1.84 [1.30-2.60],0.0005084386129988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,25593,25,1.76 [1.21-2.57],0.003436019613965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCB,Calcitonin gene-related peptide 2,22469,25,1.99 [1.11-3.56],0.0202002565111715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,25744,27,45.68 [9.74-214.16],1.246430876575814e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPG,Macrophage-capping protein,25611,27,1.88 [1.13-3.15],0.0158006546786349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASC3,Protein CASC3,21886,25,1.97 [1.04-3.72],0.0368315084995509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN4,Cerebellin-4,26026,27,0.41 [0.19-0.85],0.0176097365293516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,25813,27,4.24 [2.45-7.35],2.576374927578956e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,21934,25,2.27 [1.46-3.52],0.0002748322656615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,26083,26,3.56 [1.45-8.76],0.0056172252610763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,25724,27,2.21 [1.25-3.91],0.0062757204064687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,26127,27,5.43 [3.13-9.40],1.5679416060164371e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,26127,27,3.99 [2.20-7.23],5.169209946192686e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL18,C-C motif chemokine 18,25427,27,1.63 [1.17-2.28],0.0037830509767876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL19,C-C motif chemokine 19,26036,26,1.28 [1.07-1.54],0.0076080150163952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,26083,26,1.52 [1.19-1.94],0.0008190947012522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,25944,25,1.92 [1.28-2.88],0.001728386461968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL22,C-C motif chemokine 22,25579,25,2.06 [1.26-3.36],0.0039170576577887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,26083,26,2.62 [1.31-5.26],0.0067120018176854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,25772,24,1.83 [1.38-2.43],3.2099915607040034e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,26095,27,5.68 [3.33-9.66],1.5906606808280554e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,26026,27,2.22 [1.09-4.50],0.0276402223262774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,25809,26,4.54 [2.26-9.09],2.0153304991037456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,25809,26,4.06 [1.60-10.28],0.0031642073013191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,25242,27,3.61 [1.74-7.49],0.0005812325352666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,26083,26,4.58 [2.67-7.86],3.323367521793199e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,25899,27,3.13 [1.64-5.98],0.0005334188599523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,25809,26,1.79 [1.12-2.86],0.015315850701278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,25257,26,3.61 [1.82-7.17],0.0002411107873045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,26083,26,2.75 [1.37-5.54],0.0046236506009541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,26083,26,4.64 [1.40-15.41],0.0121444307210122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,25902,27,8.03 [5.05-12.78],1.4767278358575813e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,25641,25,3.36 [1.76-6.42],0.0002431288852617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,25823,25,9.72 [4.71-20.07],7.975700922695713e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,25213,25,0.34 [0.12-0.98],0.0451570791585851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,22039,23,15.59 [6.32-38.48],2.521114738087892e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,26036,26,3.57 [2.04-6.27],9.06389089632692e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,25932,27,5.03 [2.59-9.75],1.7613433090614383e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,25691,26,8.72 [4.69-16.21],7.472389919432795e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD36,Platelet glycoprotein 4,21882,23,2.55 [1.17-5.54],0.0179120440756655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,25691,26,10.71 [5.68-20.20],2.342963969402999e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD4,T-cell surface glycoprotein CD4,25733,24,2.24 [1.38-3.64],0.0011828796381191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,25817,25,2.78 [1.56-4.95],0.000540196622499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,25636,27,4.39 [2.53-7.61],1.3420069590692636e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,25901,25,9.76 [4.29-22.20],5.4597230566874176e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,25991,27,1.38 [1.02-1.87],0.0373198867993322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,24906,27,3.65 [2.05-6.50],1.1192477475692794e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,24851,26,2.03 [1.30-3.18],0.0018322073335272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD63,CD63 antigen,25601,25,2.18 [1.07-4.42],0.0317989420382139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,21838,23,3.33 [2.33-4.76],4.5004469302936786e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,25772,24,2.26 [1.09-4.71],0.0292558022434471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,22039,23,3.33 [1.57-7.09],0.0017642382868969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,26036,26,7.01 [3.51-14.01],3.5310189600153185e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,26083,26,4.87 [3.27-7.25],6.504794909930212e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,22521,25,4.80 [2.21-10.42],7.225310290631467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,25772,24,6.00 [2.95-12.21],7.820774842608789e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,26036,26,2.03 [1.09-3.78],0.0262883152074907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,25809,26,8.82 [1.97-39.41],0.0043795108526123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC26,Anaphase-promoting complex subunit CDC26,22372,24,1.81 [1.10-3.00],0.0200079987063761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC27,Cell division cycle protein 27 homolog,25213,25,1.63 [1.01-2.63],0.0443602269383339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,25641,25,4.64 [2.82-7.64],1.7215558928194175e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,24951,27,3.07 [2.09-4.51],1.0865013770680209e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,25988,26,1.73 [1.05-2.85],0.0327498368653518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,25813,27,2.04 [1.32-3.17],0.0014569671087809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,25813,27,6.34 [2.49-16.13],0.0001053762682539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,26036,26,2.62 [1.20-5.70],0.015487566719684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,25813,27,2.41 [1.03-5.62],0.0415161381667538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,25691,26,1.54 [1.11-2.15],0.009593637682256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,25691,26,2.31 [1.33-4.01],0.0028041749232643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,22409,24,3.62 [1.89-6.94],0.0001037789645111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,25213,25,0.42 [0.19-0.92],0.0307621843034624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,24879,24,1.66 [1.02-2.69],0.0417190203202374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,22510,25,2.74 [1.25-6.04],0.0121241063320141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,25337,26,2.62 [1.58-4.34],0.000187358180046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA2A,Chymotrypsin-like elastase family member 2A,22510,25,0.49 [0.29-0.84],0.0090021394011285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA3A,Chymotrypsin-like elastase family member 3A,26081,27,0.37 [0.22-0.62],0.0001238028716979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP43,Centrosomal protein 43,25132,26,1.65 [1.03-2.65],0.0371169423169773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES1,Liver carboxylesterase 1,25869,25,1.72 [1.20-2.46],0.0028320309196442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,25213,25,1.76 [1.01-3.06],0.0458507649721723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,22555,24,11.54 [5.27-25.27],9.83651812585067e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR2,Complement factor H-related protein 2,22386,24,2.81 [1.14-6.92],0.0243580209141104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,25813,27,7.20 [3.58-14.48],3.1308343490931474e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22469,25,4.51 [3.17-6.43],8.167144465967927e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,22389,25,2.89 [1.67-5.00],0.0001528167698581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,22510,25,1.69 [1.30-2.20],9.24614250838248e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,25939,26,3.55 [1.98-6.36],1.977781448928048e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,25230,27,2.14 [1.59-2.87],4.045843399285898e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,25901,25,4.03 [1.44-11.33],0.0081322340891657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,22510,25,5.23 [3.26-8.37],5.749094308496361e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",25736,25,2.00 [1.16-3.43],0.012252116829433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,25641,25,4.18 [1.58-11.04],0.0038803529519147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,25809,26,4.14 [1.62-10.59],0.0030590755560884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,25337,26,4.91 [2.00-12.07],0.0005293917826177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,25772,24,0.32 [0.13-0.78],0.0120162428276938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4G,C-type lectin domain family 4 member G,25772,24,3.00 [1.02-8.84],0.0464830062739791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,25729,27,6.13 [3.04-12.36],3.931789747321333e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,25213,25,2.03 [1.06-3.88],0.0332470213229273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,26083,26,2.27 [1.02-5.04],0.0449899385352923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,21886,25,2.30 [1.33-3.98],0.0027700358656799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,26026,27,11.65 [3.92-34.67],1.0112687688705124e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,22469,25,2.58 [1.04-6.36],0.0398931927694573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,25778,27,0.31 [0.15-0.66],0.0026020037617141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,25877,26,0.69 [0.48-0.99],0.0445265056430637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COCH,Cochlin,22521,25,2.72 [1.36-5.41],0.0044931246612065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL15A1,Collagen alpha-1(XV) chain,22510,25,6.49 [2.49-16.90],0.0001279590925318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,25920,26,40.23 [11.75-137.72],4.0099286464638935e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,22510,25,7.19 [2.60-19.89],0.0001464391935465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,25813,27,4.09 [2.07-8.10],5.139095552707269e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,22039,23,3.52 [1.75-7.05],0.0003948002253761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,26127,27,10.23 [6.06-17.28],3.489176244505104e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,25823,25,25.91 [10.70-62.75],5.473604692243916e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO6,Coronin-6,21797,24,2.48 [1.51-4.07],0.0003282493467059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX6B1,Cytochrome c oxidase subunit 6B1,22521,25,3.93 [1.63-9.45],0.0022455981791403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA1,Carboxypeptidase A1,26127,27,0.46 [0.27-0.78],0.0043941632346855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB1,Carboxypeptidase B,26127,27,0.51 [0.28-0.93],0.0286602076419067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,25915,26,4.54 [2.25-9.16],2.3635422686254643e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPQ,Carboxypeptidase Q,22464,25,0.39 [0.19-0.80],0.0094114599484865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPVL,Probable serine carboxypeptidase CPVL,25991,27,2.47 [1.02-5.97],0.0439775736140313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,22521,25,4.32 [2.63-7.09],7.394128076234622e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,22432,24,2.69 [1.71-4.23],1.879381766719223e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,25899,27,2.89 [1.42-5.92],0.0035963502234584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREG1,Protein CREG1,25482,27,0.32 [0.12-0.85],0.0219649777257513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,22039,23,9.98 [3.56-27.95],1.193732873381576e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,25901,25,2.47 [1.38-4.40],0.0022452317864155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,25169,24,0.61 [0.39-0.96],0.0312064583023764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,25823,25,7.75 [2.28-26.36],0.0010400241660166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,25641,25,3.12 [1.96-4.96],1.5602860620165476e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB1,Beta-crystallin B1,22521,25,2.10 [1.20-3.66],0.0091356777987965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,25944,25,12.51 [4.59-34.09],7.726666334261935e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,22523,24,3.40 [1.73-6.68],0.000379129856947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3R,Granulocyte colony-stimulating factor receptor,21882,23,2.38 [1.01-5.64],0.0480394857294942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,21807,24,1.59 [1.26-2.00],8.701439329155543e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,25865,27,14.07 [7.07-27.98],4.8544189498797575e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,25450,26,4.88 [3.03-7.85],6.982238353956009e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,22510,25,4.88 [2.27-10.50],5.025035214094495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRB1,Chymotrypsinogen B,25809,26,0.46 [0.25-0.83],0.0103647866788402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,25825,25,0.33 [0.21-0.51],6.878297227393085e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,22469,25,0.38 [0.24-0.62],0.0001123438302048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,24093,26,2.57 [1.60-4.12],9.525530996116755e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,22039,23,2.21 [1.06-4.60],0.0343551559401135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,25813,27,12.31 [4.91-30.87],8.633579108221865e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,26083,26,3.64 [1.43-9.22],0.0065153965999142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,20264,21,14.58 [4.34-49.03],1.4897182895358816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSV,Cathepsin L2,25951,27,0.73 [0.54-0.99],0.0439921867247003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,25811,27,9.54 [3.76-24.21],2.048833298122416e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL11,C-X-C motif chemokine 11,26036,26,1.42 [1.01-2.01],0.0436797581446375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,26036,26,1.40 [1.12-1.76],0.0036032794861479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL14,C-X-C motif chemokine 14,25307,25,1.48 [1.07-2.04],0.0191720532650257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,26083,27,6.73 [1.78-25.41],0.0049438176938072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL6,C-X-C motif chemokine 6,26083,26,2.06 [1.38-3.08],0.0003969657606889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,25601,27,1.47 [1.07-2.01],0.0177505294612038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,25944,25,1.93 [1.32-2.82],0.0006789182801088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAND5,DAN domain family member 5,21882,23,1.67 [1.16-2.41],0.0057236593599135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBI,Acyl-CoA-binding protein,25689,25,1.89 [1.20-2.98],0.0062575106166919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",25902,27,13.18 [5.57-31.20],4.499696328923478e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,25337,26,19.49 [6.56-57.93],9.147674582882265e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D2,DCN1-like protein 2,21705,24,1.64 [1.25-2.15],0.000379417648067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",25691,26,3.18 [2.06-4.90],1.680764325841965e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,26036,26,6.13 [2.12-17.73],0.0008242000974475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX53,Probable ATP-dependent RNA helicase DDX53,21886,25,2.51 [1.16-5.43],0.0192128715333988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,25291,27,2.01 [1.34-2.99],0.0006513710404314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,21708,23,1.93 [1.35-2.78],0.0003566543557992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,25449,26,1.28 [1.02-1.61],0.0334090789913356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKA,Diacylglycerol kinase alpha,21882,23,2.11 [1.13-3.94],0.0184687742217968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,22469,25,2.06 [1.36-3.11],0.0006698293304192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK1C,Divergent protein kinase domain 1C,21886,25,1.61 [1.05-2.46],0.0291843576366167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,25601,25,2.72 [1.74-4.26],1.156364745656958e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLK1,Protein delta homolog 1,26127,27,2.27 [1.23-4.18],0.0086451542861595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,25902,27,13.28 [6.02-29.28],1.4594682967544766e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,21934,25,1.71 [1.14-2.57],0.0097843719894592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,21934,25,0.54 [0.37-0.78],0.0009130205644459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB1,DnaJ homolog subfamily B member 1,25691,26,1.68 [1.12-2.51],0.0113889726420291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB14,DnaJ homolog subfamily B member 14,22409,24,2.24 [1.48-3.38],0.0001197458099289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,21934,25,1.65 [1.06-2.56],0.0250789938400578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,22479,24,2.86 [1.88-4.36],9.047159459417308e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,25691,26,4.83 [1.78-13.15],0.0020289991596563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,26127,27,30.27 [6.25-146.48],2.2461900435176203e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,25938,27,2.30 [1.59-3.32],8.291497987115732e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,25641,25,2.62 [1.33-5.18],0.0055105840111052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,25538,26,4.63 [2.74-7.84],1.1200306122981376e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,25613,26,0.35 [0.20-0.62],0.0003420170576972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,22352,25,4.22 [2.71-6.58],2.0543407099567668e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,25691,26,5.02 [1.83-13.77],0.001745567240556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",22409,24,1.49 [1.03-2.16],0.032438490809326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT1,Dynein light chain Tctex-type 1,21886,25,1.51 [1.03-2.20],0.0334592919224815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,25983,27,3.38 [1.40-8.17],0.006927091510974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECE1,Endothelin-converting enzyme 1,25203,25,0.33 [0.13-0.88],0.0270955322212748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,26026,27,8.35 [4.84-14.42],2.5108810102021585e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,21934,25,5.74 [1.72-19.09],0.0044116578950951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,22409,24,3.63 [2.43-5.42],2.9170040711317353e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,25855,27,6.88 [2.66-17.76],6.776194133892698e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFHD1,EF-hand domain-containing protein D1,22479,24,2.30 [1.21-4.36],0.0106695932318647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,25768,25,13.39 [6.19-28.96],4.2776457639114816e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA4,Ephrin-A4,25601,25,1.77 [1.25-2.52],0.0013379491896755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNB2,Ephrin-B2,21886,25,1.65 [1.14-2.39],0.008303178907534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,25213,25,1.93 [1.06-3.54],0.0328534347633704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,25813,27,2.07 [1.33-3.22],0.0012005325541639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5,Eukaryotic translation initiation factor 5,21807,24,1.86 [1.02-3.40],0.0441918237126762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,22521,25,4.08 [1.52-10.96],0.0053142743991817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,25307,25,1.81 [1.05-3.11],0.0322872391756971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,21807,24,2.94 [1.28-6.76],0.011371089653334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,21882,23,1.96 [1.20-3.18],0.0068580485961158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,25907,25,4.03 [1.30-12.52],0.0158609866154873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,24900,26,3.34 [2.43-4.59],9.218892129710552e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,26127,27,10.06 [5.22-19.38],5.1913435384112735e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,25593,25,3.09 [1.07-8.91],0.0368219789760635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,25772,24,1.61 [1.18-2.21],0.0030364453986727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPPK1,Epiplakin,21934,25,1.74 [1.10-2.75],0.0174666937588481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,25981,27,7.19 [3.67-14.09],9.160226313420656e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,21882,23,3.76 [1.88-7.51],0.0001721160160459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,26127,27,6.58 [3.06-14.12],1.35770496497289e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESYT2,Extended synaptotagmin-2,22469,25,1.59 [1.03-2.44],0.0349507546561376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI5,Ecotropic viral integration site 5 protein homolog,21882,23,1.63 [1.07-2.47],0.0223047389321464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EZR,Ezrin,26036,26,5.21 [1.93-14.10],0.0011454934795492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,25809,26,1.83 [1.04-3.23],0.0369460195867782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,25901,25,2.19 [1.18-4.07],0.0128579579270767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",25823,25,2.21 [1.64-2.98],2.134446968086085e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP2,"Fatty acid-binding protein, intestinal",25813,27,1.62 [1.10-2.39],0.0146361079679872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",22521,25,4.25 [3.00-6.01],3.686967703647343e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",26127,27,5.48 [3.73-8.06],5.219315862309886e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP5,Fatty acid-binding protein 5,25950,26,2.22 [1.48-3.33],0.0001105924270713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP6,Gastrotropin,25297,26,1.73 [1.12-2.68],0.0134609845364812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,25691,26,20.75 [7.73-55.72],1.769197857743111e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,25769,27,26.37 [12.91-53.85],2.6298169906699254e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,22409,24,4.65 [2.69-8.02],3.3877320395620385e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,26043,27,2.10 [1.39-3.17],0.0004057864640486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,22510,25,7.66 [3.60-16.27],1.193037146734144e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,22521,25,1.82 [1.10-3.01],0.0195729541856724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,25809,26,2.38 [1.54-3.67],9.035860709340254e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,25688,27,2.53 [1.20-5.33],0.0147237016804936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,22475,24,3.81 [1.70-8.52],0.0011394667166455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL1,Fc receptor-like protein 1,25813,27,2.35 [1.19-4.66],0.0142800644092801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,25963,26,2.23 [1.38-3.61],0.0010292839724937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,25213,25,1.65 [1.15-2.38],0.0071306840071996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",21807,24,1.81 [1.29-2.52],0.000517613294255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX2,"Ferredoxin-2, mitochondrial",21807,24,1.69 [1.08-2.66],0.0223162564574906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF2,Fibroblast growth factor 2,25772,24,1.89 [1.16-3.08],0.0103965857189883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,25983,27,1.88 [1.46-2.42],1.238271579017371e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,25987,27,2.06 [1.50-2.84],8.856630360210711e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,25307,25,3.35 [1.93-5.82],1.7863596606960017e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,25902,27,0.60 [0.39-0.93],0.021526316191504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,25902,27,20.84 [7.21-60.29],2.0931876117787924e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,22523,24,2.48 [1.39-4.41],0.0019896434736865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,22479,24,1.56 [1.05-2.33],0.028511314909232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,25641,25,3.21 [1.38-7.49],0.0069097323704427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,25641,25,4.11 [1.50-11.25],0.0060476731057287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT1,Vascular endothelial growth factor receptor 1,25650,26,3.03 [1.32-6.93],0.0087826624107111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,26083,26,3.50 [1.30-9.38],0.0128294893215966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,25775,27,8.44 [3.29-21.65],9.00076354246228e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR2,Folate receptor beta,26036,26,3.12 [1.07-9.12],0.037325705769267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,21934,25,6.09 [3.00-12.33],5.299403205117762e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,25776,25,6.34 [3.08-13.07],5.644597975273171e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUS,RNA-binding protein FUS,25175,25,2.01 [1.05-3.86],0.0344464257364835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD2,Glutamate decarboxylase 2,21882,23,1.82 [1.27-2.62],0.0011175448000836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,25691,26,4.67 [1.80-12.12],0.0015381896245717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,25691,26,4.42 [1.18-16.58],0.0276984715204596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,22469,25,1.36 [1.10-1.68],0.0038462355478687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP4,Guanylate-binding protein 4,25203,25,2.01 [1.23-3.29],0.0052778821462309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,25213,25,1.87 [1.42-2.45],6.129473074551882e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,21511,23,2.17 [1.38-3.39],0.0007403300554779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",25691,26,2.85 [1.18-6.89],0.0200131236853058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,26127,27,2.98 [2.39-3.72],3.24033599613216e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,25203,25,2.72 [1.69-4.39],4.101819873526387e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,25983,27,18.86 [8.11-43.87],9.119478678241614e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA2,GDNF family receptor alpha-2,25691,26,3.70 [1.25-10.95],0.0182251763659435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT5,Glutathione hydrolase 5 proenzyme,25641,25,6.41 [3.14-13.11],3.535153626229267e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIGYF2,GRB10-interacting GYF protein 2,22479,24,1.66 [1.05-2.61],0.0296994584689537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,22469,25,8.62 [4.60-16.14],1.669956367531235e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIT1,ARF GTPase-activating protein GIT1,21882,23,1.55 [1.02-2.34],0.0390730449353897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GKN1,Gastrokine-1,24713,24,2.94 [1.09-7.91],0.0324068311691205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,26036,26,6.38 [2.40-17.00],0.0002084426593162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC1,Glypican-1,26026,27,5.36 [1.84-15.58],0.0020368785598218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPI,Glucose-6-phosphate isomerase,22523,24,2.31 [1.13-4.70],0.0209727402586197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPKOW,G-patch domain and KOW motifs-containing protein,25203,25,2.11 [1.15-3.86],0.0159180388260913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,25112,26,13.55 [4.97-36.99],3.599259465330265e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,22409,24,2.88 [1.79-4.64],1.4113684136999336e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,25337,26,4.67 [3.12-6.98],6.532723135237847e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,22389,25,1.67 [1.05-2.66],0.0308555162247028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,25690,25,5.49 [1.48-20.38],0.0108932002925244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",25691,26,1.91 [1.23-2.97],0.0041657708691785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,22446,23,0.43 [0.20-0.94],0.0339624772205627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,25689,26,14.03 [7.60-25.87],2.763839906162279e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,26026,27,1.33 [1.05-1.69],0.0193582437065056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,25991,27,3.46 [2.35-5.08],3.045821978857345e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,25809,26,7.18 [3.59-14.38],2.63208217733742e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,22039,23,7.31 [1.90-28.09],0.0037602631231898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,22521,25,6.68 [1.76-25.35],0.0052315218622892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,26083,26,4.98 [2.61-9.49],1.114811429261704e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,22469,25,2.04 [1.25-3.33],0.0041930929704545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,22428,25,2.40 [1.71-3.37],3.80938831673512e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,22479,24,1.63 [1.07-2.47],0.0219328147340927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",22479,24,7.81 [2.13-28.62],0.001919193339943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",25772,24,5.29 [2.27-12.32],0.0001152537524353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMCN2,Hemicentin-2,22000,23,2.54 [1.24-5.23],0.0113124776692624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX2,Heme oxygenase 2,25203,25,1.81 [1.05-3.12],0.0316517412045995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,25512,25,2.94 [1.75-4.94],4.6446405705069375e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,22479,24,2.01 [1.21-3.35],0.007354176006864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,25213,25,0.37 [0.14-0.98],0.0453542742119721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRAS,GTPase Hras,22049,24,1.27 [1.01-1.60],0.0428820128280863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS1BP3,HCLS1-binding protein 3,21934,25,1.73 [1.12-2.67],0.0134199677563762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,25691,26,2.41 [1.11-5.23],0.0254582706166854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,21882,23,6.52 [3.47-12.23],5.435954413021946e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,25772,24,0.36 [0.16-0.82],0.0152582659120287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,22389,25,2.53 [1.54-4.16],0.0002673667927502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,26026,27,8.45 [4.87-14.66],3.343418857917255e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,25601,27,7.45 [4.05-13.71],1.110364080343968e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,26127,27,16.62 [4.40-62.82],3.438504540803187e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,26127,27,3.51 [1.19-10.37],0.023191189995368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,26127,27,5.25 [1.92-14.32],0.0012112799136917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM4,Intercellular adhesion molecule 4,25772,24,0.46 [0.24-0.87],0.0168375710131868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,26026,27,3.67 [1.62-8.30],0.0018532808522618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,21861,24,3.59 [1.78-7.25],0.0003547668588085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,25944,25,6.37 [1.35-30.06],0.0194204020624415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNLR1,Interferon lambda receptor 1,25772,24,2.15 [1.26-3.65],0.0047341463903574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFT20,Intraflagellar transport protein 20 homolog,21886,25,2.14 [1.06-4.30],0.0339510006092629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGBP1,Immunoglobulin-binding protein 1,22479,24,1.79 [1.01-3.18],0.0472304489425346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,25691,26,2.74 [1.45-5.15],0.001822102225469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,25809,26,9.35 [2.47-35.34],0.000990356074699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,26081,26,2.13 [1.23-3.69],0.006778527440741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,25899,27,0.48 [0.29-0.82],0.0066420354991637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,25464,26,5.52 [3.73-8.16],1.1643507422406912e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,25683,27,8.00 [4.71-13.59],1.3273803312657142e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,26127,27,2.89 [1.69-4.92],9.687934570124835e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,25813,27,6.33 [3.52-11.38],6.71936009485514e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,22511,24,1.71 [1.01-2.91],0.0461487058521279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,25691,26,2.97 [1.86-4.73],4.807721326470485e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,25813,27,8.12 [4.65-14.19],1.9369774922038882e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,22521,25,1.93 [1.27-2.92],0.0020710678102179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,25307,25,1.39 [1.11-1.74],0.0044770389995525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,25691,26,2.36 [1.76-3.16],1.0179148501988776e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,26083,26,4.10 [2.39-7.05],3.24235046892226e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,25307,25,2.51 [1.73-3.65],1.5329982039790675e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,21882,23,2.29 [1.20-4.37],0.0119047860669041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,25307,25,2.82 [1.06-7.49],0.0372236670593592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL16,Pro-interleukin-16,26083,26,2.63 [1.51-4.59],0.0006711234849831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,25307,25,1.45 [1.01-2.10],0.0451766903983801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17D,Interleukin-17D,25307,25,2.18 [1.25-3.80],0.0060011082476897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,25738,25,1.92 [1.04-3.52],0.0360502166709611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,25899,27,8.01 [4.21-15.22],2.1749878682844155e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,26083,26,5.22 [2.15-12.67],0.0002635974038038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,25163,25,2.14 [1.50-3.07],3.0546011307343044e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,25768,25,11.73 [4.84-28.38],4.798202283260436e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,25783,25,12.03 [1.91-75.57],0.0079869849786726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,25778,25,2.14 [1.41-3.26],0.0003541323167649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,22389,25,1.94 [1.38-2.73],0.0001430423350175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,25605,27,5.88 [3.53-9.78],9.370714694916909e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36A,Interleukin-36 alpha,21882,23,1.63 [1.09-2.43],0.018181948931764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36G,Interleukin-36 gamma,21783,23,1.89 [1.39-2.57],4.720410122066223e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,25772,24,2.45 [1.17-5.14],0.0175970656725021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,25691,26,1.42 [1.06-1.90],0.0185550524432239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,25813,27,4.09 [1.61-10.42],0.0031110072891861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7R,Interleukin-7 receptor subunit alpha,25809,26,0.45 [0.24-0.84],0.0117592729698628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,22389,25,2.23 [1.42-3.51],0.0004938908883719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,22039,23,3.13 [1.58-6.18],0.0010307981980632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",21934,25,2.43 [1.44-4.10],0.0009212125272145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL3,Insulin-like 3,22469,25,0.50 [0.31-0.80],0.0041969673885217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,22409,24,1.78 [1.26-2.51],0.0010243189261216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,25691,26,1.79 [1.02-3.15],0.0441622314637145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,25772,24,0.33 [0.12-0.87],0.0258987157160148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,25809,26,5.56 [1.69-18.30],0.004732924005365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAL,Integrin alpha-L,21882,23,2.74 [1.04-7.19],0.0407253129852257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,25646,26,5.39 [2.04-14.24],0.0006702338245899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,26026,27,2.29 [1.25-4.18],0.0071675736118554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,22510,25,4.46 [2.03-9.80],0.000198394590106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,22389,25,2.18 [1.43-3.33],0.0002848186685753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,26036,26,7.88 [3.52-17.66],5.230432773984972e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,22039,23,2.75 [1.65-4.57],0.0001041953814913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JPT2,Jupiter microtubule associated homolog 2,22409,24,1.64 [1.02-2.62],0.0407769626579205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,25691,26,2.52 [1.09-5.87],0.0315549193867217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNIP4,Kv channel-interacting protein 4,25203,25,0.32 [0.11-0.87],0.0255471205310718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCTD5,BTB/POZ domain-containing protein KCTD5,22052,25,1.83 [1.17-2.86],0.0086492736962465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,21807,24,2.01 [1.25-3.24],0.0041948042901314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF20B,Kinesin-like protein KIF20B,21797,24,1.43 [1.03-1.98],0.0339100868675764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF22,Kinesin-like protein KIF22,21807,24,1.48 [1.02-2.13],0.0368815004530372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIT,Mast/stem cell growth factor receptor Kit,25854,27,0.61 [0.39-0.97],0.0385669481881845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLHL41,Kelch-like protein 41,22479,24,1.86 [1.13-3.07],0.0149955929845222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,25662,27,2.48 [1.45-4.24],0.0008979874335552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,26026,27,2.33 [1.56-3.47],3.386097039590244e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,26083,26,9.12 [4.59-18.12],2.738616825324662e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,26083,26,2.30 [1.17-4.54],0.0162268228823821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,21882,23,1.92 [1.26-2.91],0.0022013860810958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,22469,25,2.79 [1.52-5.09],0.0008778092951831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",25691,26,1.66 [1.18-2.32],0.0034094311191573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",25736,24,2.78 [1.91-4.04],1.0040415955940341e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT6C,"Keratin, type II cytoskeletal 6C",21807,24,1.77 [1.06-2.98],0.0306091669165056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",21797,24,1.62 [1.29-2.04],3.3287769002226855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,25691,26,1.99 [1.01-3.91],0.0468446240684832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,25823,25,4.31 [2.56-7.25],3.906635707365491e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,21934,25,4.14 [1.15-14.90],0.0298432528491541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,26039,26,2.17 [1.14-4.13],0.0178719415274476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LATS1,Serine/threonine-protein kinase LATS1,21882,23,1.71 [1.08-2.70],0.0212165955202293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,25593,25,7.54 [4.12-13.78],5.197851516623684e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,22479,24,1.92 [1.45-2.54],5.927229473683231e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,25025,27,3.63 [2.07-6.35],6.465327812657483e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,22479,24,1.62 [1.07-2.44],0.0217563718421207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LECT2,Leukocyte cell-derived chemotaxin-2,22521,25,1.68 [1.05-2.70],0.031603750391049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,22479,24,2.56 [1.61-4.06],7.173845902845346e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,25813,27,6.87 [3.44-13.76],5.12815270638284e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,25871,26,4.25 [2.53-7.14],4.7191649356289494e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,22555,24,2.70 [1.40-5.18],0.0028877359625941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,25823,25,5.81 [3.70-9.13],1.9570864594865457e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS7_LGALS7B,Galectin-7,25730,27,2.01 [1.12-3.60],0.0184861125806233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,25817,25,8.49 [3.57-20.14],1.2468144235818087e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,25772,24,6.40 [2.54-16.09],8.10456867798979e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,22510,25,0.75 [0.64-0.87],0.0001389202114039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,21807,24,1.73 [1.08-2.78],0.0222580304522029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,25769,27,5.07 [1.77-14.49],0.0024789099302741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,25307,25,4.46 [2.37-8.40],3.543232831193433e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,22469,25,5.25 [2.75-10.03],5.272067123983701e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,22479,24,3.33 [2.22-5.01],7.1222264504490964e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,25021,25,2.13 [1.29-3.53],0.0032175474324718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,21807,24,1.91 [1.26-2.90],0.0022851126276088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,25813,27,8.54 [4.01-18.17],2.6137465056965484e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,25691,26,2.54 [1.59-4.05],9.701860345533027e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRN1,Leucine-rich repeat neuronal protein 1,25307,25,0.36 [0.14-0.93],0.0354546574333394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSP1,Lymphocyte-specific protein 1,25772,24,2.65 [1.22-5.76],0.0139463348277275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,26127,27,5.92 [2.58-13.57],2.695373848431497e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,25213,25,1.86 [1.29-2.70],0.001017107390132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,25702,25,8.97 [3.74-21.50],8.59079927210462e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,25695,25,2.71 [1.37-5.35],0.004191107595974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY75,Lymphocyte antigen 75,25772,24,3.36 [1.17-9.63],0.0238421956931826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,25536,26,5.68 [2.12-15.20],0.0005450466211977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,22555,24,18.46 [3.77-90.31],0.0003193993943465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,25551,25,1.93 [1.33-2.79],0.0004983330866259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,25902,27,4.63 [1.54-13.97],0.0064788549344607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,22469,25,2.01 [1.09-3.71],0.0245494769889298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,22409,24,2.20 [1.26-3.83],0.0055775102586462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK13,Mitogen-activated protein kinase 13,21705,24,2.02 [1.14-3.59],0.0164520872377529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN3,Matrilin-3,25601,25,0.35 [0.13-0.98],0.0465836616332707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,26127,27,3.13 [2.14-4.59],5.080081977856167e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",22479,24,1.62 [1.00-2.61],0.0495682912772193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,25709,27,3.26 [1.54-6.94],0.0020916574733798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDH1,"Malate dehydrogenase, cytoplasmic",22387,24,2.60 [1.30-5.21],0.0070275110978091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,25826,27,1.87 [1.39-2.52],3.333406850752653e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,22039,23,0.42 [0.20-0.90],0.0251572607782708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1A,Meprin A subunit alpha,22409,24,1.72 [1.04-2.82],0.0335103728596566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1B,Meprin A subunit beta,25813,27,0.75 [0.58-0.96],0.0242896725466425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,22039,23,6.12 [1.87-20.03],0.0027501333763618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP5,Microfibrillar-associated protein 5,26127,27,3.71 [1.65-8.34],0.0015030037731359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,25809,26,7.85 [4.14-14.88],2.6126371662046165e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,25307,25,3.01 [1.78-5.08],3.748305566633649e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,25691,26,1.88 [1.32-2.69],0.000524939670134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP1,Interstitial collagenase,24818,26,1.72 [1.11-2.65],0.0147596768107583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,25780,25,2.10 [1.33-3.30],0.0013253539812918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,25821,27,3.92 [2.47-6.23],7.57008303473166e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP15,Matrix metalloproteinase-15,22521,25,1.64 [1.11-2.42],0.0123155928086587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP3,Stromelysin-1,25809,26,2.32 [1.43-3.77],0.0006542012115991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,25293,26,3.96 [1.99-7.88],9.068923995736143e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,22523,24,6.52 [2.44-17.45],0.0001857293547773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL52,"39S ribosomal protein L52, mitochondrial",21669,24,5.55 [2.51-12.28],2.364654394468487e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,25655,26,2.51 [1.50-4.21],0.0004916263940773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSMB,Beta-microseminoprotein,25720,26,2.89 [2.02-4.13],6.790243895808441e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,26036,26,3.99 [2.24-7.10],2.602691040407616e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MST1,Hepatocyte growth factor-like protein,22172,23,3.65 [1.10-12.07],0.0340283337651532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTDH,Protein LYRIC,21882,23,1.72 [1.15-2.58],0.0088012408989389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,25203,25,5.92 [3.80-9.24],4.5068540795803105e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC2,Mucin-2,22510,25,1.60 [1.08-2.38],0.0203920863489002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,25307,25,2.06 [1.45-2.93],5.231892669233341e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",22521,25,2.76 [1.99-3.83],1.0994803038073623e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC2,"Myosin-binding protein C, fast-type",21934,25,1.44 [1.11-1.88],0.0057893813918217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYDGF,Myeloid-derived growth factor,22521,25,1.68 [1.14-2.47],0.0086729012325267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,21934,25,2.83 [1.80-4.44],5.877744736715191e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",21886,25,2.16 [1.52-3.07],1.5402121915236447e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,22039,23,1.56 [1.02-2.38],0.0412866660300091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,25910,25,1.89 [1.02-3.51],0.043885815614356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",22479,24,3.61 [1.62-8.08],0.0017436934326016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,25902,27,17.29 [6.77-44.19],2.6216252299919323e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,26036,26,0.68 [0.47-0.97],0.0333369968845776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,25733,24,5.36 [2.40-11.96],4.130414156061114e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,22409,24,7.07 [3.67-13.61],4.880691802630806e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,26026,27,13.21 [4.64-37.58],1.30662815403609e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",25213,25,1.51 [1.16-1.96],0.0020601379110087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEB,Nebulin,21807,24,1.91 [1.03-3.52],0.0392794637173829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,25769,27,18.16 [8.58-38.39],3.293035463748973e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,25902,27,6.23 [3.37-11.52],5.438614496474265e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,25120,25,4.89 [3.37-7.08],4.976911938013047e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,25902,27,0.60 [0.43-0.84],0.003133226382814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,26083,26,32.02 [13.28-77.22],1.1844079867212452e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,21807,24,1.83 [1.12-3.01],0.0164073081296358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,22521,25,2.46 [1.27-4.80],0.0079580281540245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,22469,25,5.39 [3.17-9.15],4.6563292911324144e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,21505,23,7.18 [1.93-26.79],0.0033215350581128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,25809,26,5.43 [2.61-11.32],6.297481040803348e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",25203,25,3.97 [2.44-6.44],2.5570461145962608e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",25203,25,1.80 [1.36-2.38],4.161457115086349e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,26127,27,9.07 [1.31-62.88],0.0255957455121614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPC2,NPC intracellular cholesterol transporter 2,22126,25,1.75 [1.23-2.48],0.0018403338445643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPL,N-acetylneuraminate lyase,22521,25,2.86 [1.64-5.00],0.0002276183343814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX1,Neuronal pentraxin-1,25809,26,2.63 [1.22-5.66],0.0136617020519637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,26026,27,4.99 [2.68-9.29],4.0474271208620413e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,25813,27,4.84 [2.05-11.40],0.0003144813108248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,25944,27,4.26 [1.33-13.63],0.014715226621752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,22469,25,2.68 [2.02-3.57],1.0424062224956928e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,25813,27,1.61 [1.20-2.15],0.0014092770600219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,25978,27,3.67 [1.64-8.24],0.0015954955251553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUMB,Protein numb homolog,21882,23,1.68 [1.03-2.76],0.0386471463185089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH3,Neurexophilin-3,21882,23,3.88 [1.16-12.95],0.0276814547698962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,22479,24,4.78 [2.94-7.77],2.6403761366058017e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGFR,Opioid growth factor receptor,25691,26,4.44 [1.82-10.84],0.0010832722794136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,25809,26,5.79 [3.21-10.45],5.5205761600792735e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,21213,21,1.68 [1.18-2.38],0.00389639288256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,25944,25,0.50 [0.25-1.00],0.0492280008003546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,25691,26,0.51 [0.29-0.89],0.0168270012857841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,25867,25,4.16 [1.45-11.95],0.0081400153750204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSM,Oncostatin-M,25651,24,1.90 [1.17-3.11],0.0100741424133353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD7B,OTU domain-containing protein 7B,22479,24,2.05 [1.13-3.72],0.0179426551496931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,26036,26,1.48 [1.14-1.91],0.0033023231630154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PACS2,Phosphofurin acidic cluster sorting protein 2,21807,24,2.46 [1.41-4.28],0.0014299070764938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,25337,26,2.62 [1.73-3.97],4.870989847973464e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,22294,24,6.46 [3.92-10.65],2.612024227324385e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,22469,25,5.54 [3.43-8.94],2.3433560592064014e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAXX,Protein PAXX,22039,23,2.34 [1.15-4.76],0.019129977876897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,22409,24,2.22 [1.24-3.95],0.0071096510246776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCARE,Photoreceptor cilium actin regulator,21797,24,1.43 [1.10-1.87],0.0076439878441309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,25813,27,5.60 [2.95-10.65],1.488101904564655e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,22409,24,2.04 [1.20-3.49],0.0089774598148367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH9,Protocadherin-9,22409,24,2.71 [1.06-6.93],0.0377284715660997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,26127,27,4.16 [1.90-9.13],0.0003759065510806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,22521,25,1.58 [1.07-2.34],0.0216127610796499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,25989,27,3.04 [1.97-4.67],4.618442419883454e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,25691,26,3.87 [2.14-6.98],7.147083650147693e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD5,Programmed cell death protein 5,26036,26,2.01 [1.15-3.49],0.0134774769097907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD6,Programmed cell death protein 6,25813,27,2.48 [1.13-5.44],0.0231972234573524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,25813,27,7.21 [3.42-15.21],2.1199562876005586e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,21882,23,2.37 [1.31-4.29],0.0043767561896335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,22039,23,1.91 [1.17-3.14],0.0103627625409589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,25997,26,2.89 [1.65-5.04],0.0001897039063245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,22409,24,2.89 [1.69-4.96],0.0001098231412135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,25641,25,4.57 [2.66-7.84],3.6977180995820245e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI16,Peptidase inhibitor 16,22523,24,8.29 [1.77-38.78],0.0072177058427363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,25456,25,2.45 [1.77-3.38],6.183278544602837e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,25473,26,9.73 [4.53-20.88],5.260604638277555e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,25809,26,12.78 [6.38-25.57],6.145562873818619e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,25809,26,10.23 [4.97-21.06],2.8020709929124287e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,25813,27,7.70 [3.92-15.11],3.064619365003954e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,22039,23,0.56 [0.35-0.90],0.0159210364411432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,22521,25,6.87 [1.82-25.93],0.0044583244370189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,21807,24,2.20 [1.36-3.56],0.001268415475599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,25902,27,4.84 [1.46-16.03],0.0098462606423706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G1B,Phospholipase A2,26080,27,0.72 [0.51-1.00],0.0469002218725638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,25653,25,21.85 [8.64-55.30],7.441544995629038e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLB1,"Phospholipase B1, membrane-associated",22469,25,0.39 [0.22-0.72],0.0023490022449733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",22469,25,1.56 [1.04-2.36],0.032528969945725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,22469,25,1.72 [1.05-2.82],0.0321983004218821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN1,Perilipin-1,25203,25,2.87 [1.90-4.35],6.403010199109983e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,25813,27,3.62 [1.94-6.76],5.209685293441039e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLSCR3,Phospholipid scramblase 3,22434,25,2.63 [1.47-4.70],0.0011674798446085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,26006,27,2.11 [1.36-3.28],0.0008638441670151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,21882,23,1.64 [1.18-2.28],0.0033380459946408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",25691,26,2.48 [1.58-3.90],7.526271943834409e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,25944,25,0.65 [0.48-0.88],0.0055821806678975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPL,Periplakin,21882,23,2.58 [1.44-4.63],0.0014560881626211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,22479,24,2.10 [1.31-3.36],0.0020220560305772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,22409,24,1.41 [1.03-1.94],0.0308244068775762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,22510,25,33.36 [11.76-94.67],4.347056786533186e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,25965,27,3.27 [2.18-4.90],1.0400561747741344e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,25823,25,4.84 [1.98-11.86],0.0005618740695274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,22510,25,2.73 [1.47-5.04],0.0013949301771089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,22430,25,1.72 [1.06-2.80],0.0281422810715884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,25213,25,1.68 [1.04-2.72],0.0344396015328999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,21934,25,3.67 [1.57-8.58],0.0026947458493675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,21882,23,2.05 [1.39-3.01],0.0002721531363569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS27,Serine protease 27,25729,27,3.23 [1.48-7.03],0.003166823738004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,25730,25,5.78 [2.84-11.79],1.3788539843531242e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTN3,Myeloblastin,25139,26,2.11 [1.40-3.18],0.0003331296132447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,22292,25,3.49 [2.15-5.67],4.656945271471246e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,25641,25,2.21 [1.54-3.17],1.816198251928854e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSIP1,PC4 and SFRS1-interacting protein,25772,24,1.60 [1.10-2.33],0.0143888714717392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME2,Proteasome activator complex subunit 2,25521,25,2.79 [1.13-6.85],0.0256864667165262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSRC1,Proline/serine-rich coiled-coil protein 1,25213,25,1.79 [1.14-2.80],0.0113265059191851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,25601,26,5.86 [3.40-10.10],1.9705834539651767e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGES2,Prostaglandin E synthase 2,21706,23,1.95 [1.02-3.72],0.0421519449077038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,25203,25,2.91 [1.56-5.40],0.0007399013117018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,21836,23,2.32 [1.39-3.90],0.001393002507241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,22521,25,3.23 [1.55-6.73],0.0017467451760468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,22510,25,8.25 [3.73-18.24],1.8768660573517415e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,22409,24,3.34 [1.38-8.06],0.0073461116883582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,25553,25,2.94 [1.08-8.00],0.0345060260407444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,22469,25,2.46 [1.02-5.92],0.0451151968258438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,26036,26,2.88 [1.40-5.91],0.0040228276700782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,21807,24,2.37 [1.74-3.23],5.1586668844620244e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PZP,Pregnancy zone protein,22555,24,0.39 [0.19-0.77],0.0064343960379712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,25845,27,4.96 [2.56-9.59],2.022954764701204e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB37,Ras-related protein Rab-37,25307,25,1.42 [1.02-1.98],0.0400397525811288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,25772,24,0.35 [0.17-0.71],0.0038341765751531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP1,Ran-specific GTPase-activating protein,21934,25,1.93 [1.04-3.57],0.0367054237773913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANGAP1,Ran GTPase-activating protein 1,25213,25,0.30 [0.11-0.80],0.0156368835491746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES1,Retinoic acid receptor responder protein 1,25213,25,1.97 [1.16-3.35],0.0117795569745716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,25944,27,2.52 [1.59-4.00],7.962370884874654e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,22479,24,2.84 [2.12-3.81],3.192125841312962e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,25691,26,2.25 [1.54-3.27],2.519831694005068e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,25691,26,2.22 [1.40-3.53],0.0007291427279172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,22409,24,1.96 [1.23-3.11],0.0044987537000342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,25644,26,3.69 [2.58-5.28],8.16583236004967e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,26127,27,2.87 [2.02-4.08],3.705681137283743e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,26127,27,3.00 [2.05-4.40],1.8841936413917943e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,25867,25,5.70 [3.36-9.69],1.2243212559714291e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,25809,26,11.32 [5.13-24.99],1.913344490814152e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,25813,27,2.37 [1.86-3.02],4.446337653280061e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,25691,26,2.35 [1.03-5.37],0.0430832688334764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,25744,26,3.79 [2.24-6.41],6.689543140401495e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMA,Repulsive guidance molecule A,26036,26,3.03 [1.03-8.94],0.0444807568743654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,26036,26,9.22 [3.50-24.31],7.0586703151829725e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,22523,24,4.21 [3.01-5.89],4.828816603167933e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,21934,25,2.32 [1.73-3.10],1.8474298235426183e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,21768,24,4.38 [2.34-8.18],3.773648279499352e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,22355,24,2.97 [2.16-4.10],3.0587990700523994e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,26001,27,5.39 [3.44-8.44],1.9060938633349293e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,21934,25,3.07 [2.23-4.24],8.446477182795649e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,25867,25,5.48 [2.14-14.03],0.0003925931340242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,25813,27,6.27 [2.29-17.19],0.0003625494694495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPL14,60S ribosomal protein L14,21934,25,2.04 [1.18-3.55],0.0112248514592998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,26026,27,3.48 [1.53-7.91],0.0029325455857421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,26026,27,3.52 [2.42-5.12],4.7948311696581596e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A13,Protein S100-A13,21882,23,2.46 [1.26-4.83],0.0087110992778238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100P,Protein S100-P,25337,26,2.01 [1.37-2.95],0.0003850494765991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SARG,Specifically androgen-regulated gene protein,22428,25,1.70 [1.17-2.46],0.0052027461636998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCAMP3,Secretory carrier-associated membrane protein 3,25691,26,1.60 [1.09-2.35],0.0171730260428682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,26036,26,13.83 [7.01-27.26],3.4266658987477866e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,25172,25,6.96 [3.81-12.70],2.5367100745800896e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,26127,27,2.85 [1.36-5.98],0.0055391591298655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,26036,26,5.59 [2.13-14.64],0.0004688507390207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,25900,27,9.12 [4.14-20.12],4.292101554293516e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,25307,25,2.48 [1.41-4.37],0.0017022128756672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCIN,Adseverin,21797,24,1.49 [1.01-2.19],0.0424910576187861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,21934,25,4.88 [2.69-8.86],1.917539892152879e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,21845,25,1.99 [1.00-3.94],0.048660553433809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,22521,25,4.44 [2.39-8.24],2.317884236459877e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,25813,27,2.58 [1.50-4.44],0.0006556846774927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,21934,25,2.73 [1.81-4.13],1.7996620365841904e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELPLG,P-selectin glycoprotein ligand 1,25772,24,4.42 [1.44-13.55],0.0093687661359466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,25813,27,12.86 [4.42-37.45],2.816491421457931e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA6C,Semaphorin-6C,21882,23,2.20 [1.05-4.63],0.0371733393795012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,26043,27,3.60 [2.00-6.46],1.802953702565525e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,22423,25,1.61 [1.14-2.27],0.0073808916769023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA1,Alpha-1-antitrypsin,22116,23,26.07 [2.96-229.72],0.0033100573413144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA7,Thyroxine-binding globulin,22555,24,5.76 [1.30-25.51],0.0211116031844314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,25557,26,2.09 [1.45-3.00],7.182927907802106e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB8,Serpin B8,26083,26,1.56 [1.03-2.35],0.0337900816625592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,22218,23,8.62 [3.62-20.53],1.1311669318738162e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,25561,25,2.10 [1.19-3.69],0.0100685511825677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP4,Secreted frizzled-related protein 4,22039,23,3.07 [1.19-7.93],0.0207352384988123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2D1A,SH2 domain-containing protein 1A,25772,24,1.61 [1.06-2.44],0.0252039429749732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,22510,25,4.96 [3.49-7.04],3.3587951780889202e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,25944,25,3.75 [1.97-7.12],5.515814149800553e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,25772,24,4.36 [2.15-8.86],4.603628190409035e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,25809,26,1.87 [1.20-2.92],0.0060158982831216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,26026,27,3.52 [1.86-6.66],0.0001071152429247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,25813,27,9.43 [4.13-21.52],9.86554075664825e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,25878,26,5.84 [2.37-14.40],0.0001272766429701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,25786,25,5.45 [2.83-10.51],4.219883989038635e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,25307,25,3.39 [1.89-6.08],4.320392968222493e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP1,Src kinase-associated phosphoprotein 1,25593,25,1.62 [1.06-2.47],0.0254645677712437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,25307,25,1.91 [1.14-3.20],0.014119680261189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,25213,25,3.97 [1.99-7.92],9.443502346431968e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,25213,25,3.07 [1.80-5.23],3.817645844663661e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC16A1,Monocarboxylate transporter 1,25203,25,1.53 [1.08-2.17],0.0166527725065118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC1A4,Neutral amino acid transporter A,21886,25,1.78 [1.12-2.84],0.014712270888423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,21705,24,0.31 [0.11-0.88],0.0273803313586961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,22409,24,1.59 [1.12-2.25],0.0095820852717896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK6,SLIT and NTRK-like protein 6,25337,26,3.29 [1.69-6.40],0.0004578669830202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,22409,24,1.55 [1.02-2.35],0.0405882355286319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,22347,25,1.89 [1.17-3.06],0.0092998493729269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD2,Mothers against decapentaplegic homolog 2,22389,25,1.66 [1.03-2.69],0.0383317939869259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,26026,27,5.29 [2.39-11.68],3.83472317929908e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,25944,25,3.22 [1.63-6.36],0.0007542016910741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,25907,25,0.58 [0.35-0.98],0.0404256666757907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,25641,25,2.90 [1.77-4.75],2.3365674797106174e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',22469,25,1.96 [1.38-2.80],0.000183585433381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX9,Sorting nexin-9,25813,27,1.78 [1.12-2.84],0.015210490138838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,25213,25,4.76 [2.81-8.07],6.9700044839436835e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOST,Sclerostin,25769,27,2.44 [1.06-5.60],0.0361780797324526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX9,Transcription factor SOX-9,21886,25,6.73 [2.30-19.68],0.0005037941308629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,25809,26,3.44 [2.29-5.17],2.842588975495971e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK2,Serine protease inhibitor Kazal-type 2,22039,23,2.62 [1.01-6.76],0.0467897566521287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,25772,24,3.48 [2.47-4.90],9.84481221131733e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK6,Serine protease inhibitor Kazal-type 6,26026,27,2.63 [1.33-5.21],0.0054341643226683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,25944,25,3.16 [1.40-7.15],0.005615311766976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT3,Kunitz-type protease inhibitor 3,22409,24,0.75 [0.58-0.97],0.0268486844761127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,25867,25,2.92 [1.67-5.13],0.0001835505171979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,25688,27,11.20 [5.21-24.04],5.79496903566722e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR3,Small proline-rich protein 3,22469,25,1.97 [1.24-3.13],0.0043255522865579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRP14,Signal recognition particle 14 kDa protein,25691,26,1.77 [1.10-2.86],0.018808296648126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPK2,SRSF protein kinase 2,25772,24,1.46 [1.01-2.12],0.0468797876910877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,22521,25,3.69 [1.36-10.04],0.0104121093822603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,22409,24,1.99 [1.08-3.69],0.0278719934236013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",26127,27,5.34 [1.82-15.70],0.0023108762857056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,26036,26,3.46 [1.90-6.31],5.297652543056157e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK11,Serine/threonine-protein kinase STK11,25337,26,1.62 [1.04-2.53],0.0339620382182976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD4,Sushi domain-containing protein 4,22389,25,2.02 [1.19-3.43],0.0089153881902923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SV2A,Synaptic vesicle glycoprotein 2A,21886,25,1.61 [1.04-2.50],0.0313017070564153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SWAP70,Switch-associated protein 70,22409,24,2.50 [1.25-4.99],0.0097381845142318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TADA3,Transcriptional adapter 3,22389,25,2.51 [1.05-5.97],0.0375343021033096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,25691,26,5.38 [2.65-10.91],3.1278229696499937e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TALDO1,Transaldolase,22416,25,2.25 [1.08-4.71],0.0306215312944553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCA,Tubulin-specific chaperone A,22039,23,1.63 [1.04-2.57],0.0334231356750831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,26081,26,3.26 [1.90-5.61],1.827207074491995e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,25902,27,5.84 [1.42-23.98],0.0142479766807806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,25677,26,2.67 [1.95-3.65],7.333963334980614e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,25901,25,3.58 [2.30-5.57],1.564005781654504e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,25780,27,2.61 [1.95-3.49],1.1839627893204642e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,25816,27,1.74 [1.08-2.82],0.0232134236014737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,25772,24,2.98 [1.66-5.35],0.000255012758595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,26039,26,2.81 [1.45-5.44],0.0021818347741335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,21882,23,2.88 [1.19-6.95],0.0187149025651032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,25902,27,6.28 [3.59-10.97],1.0910717168537836e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR3,Transforming growth factor beta receptor type 3,26127,27,3.16 [1.17-8.53],0.0235616477876451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,22523,24,11.68 [4.45-30.68],6.040577529558737e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,25813,27,9.75 [3.69-25.71],4.21268037154467e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,25809,26,3.28 [1.81-5.94],9.092852178385924e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,26036,26,6.78 [2.67-17.24],5.8536115827722505e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,22092,25,2.45 [1.56-3.87],0.0001075276597828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,25515,27,5.19 [2.81-9.58],1.466307619363074e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP2,Metalloproteinase inhibitor 2,22521,25,1.80 [1.11-2.92],0.0168849066365643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,25722,27,8.22 [2.05-32.94],0.0029362112797656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,22423,25,2.46 [1.62-3.74],2.4366274512693325e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,25691,26,1.76 [1.20-2.60],0.004174171462024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMSB10,Thymosin beta-10,25809,26,2.11 [1.32-3.39],0.0018736644994872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,25293,26,2.11 [1.54-2.89],2.8946796702002866e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,22409,24,2.23 [1.24-4.02],0.0072691380166434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,25641,25,3.53 [2.53-4.95],1.8717636934524098e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,25641,25,1.74 [1.40-2.16],8.052886161835906e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,25860,26,3.10 [1.41-6.81],0.0048289133119003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,26083,26,9.61 [5.65-16.35],7.072875812993204e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,25823,25,5.50 [2.25-13.43],0.0001813877585948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,25902,27,10.78 [6.37-18.25],8.200506231088606e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,25867,25,3.10 [2.00-4.81],4.267286140441356e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,25307,25,2.21 [1.35-3.62],0.0016320759044959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,25867,25,13.94 [6.46-30.07],1.8423492907753987e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,22039,23,3.07 [1.26-7.47],0.0132734341473995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,26026,27,5.58 [2.83-10.98],6.524445254574377e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,25809,26,13.98 [7.22-27.06],5.152652079901789e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,25809,26,2.16 [1.63-2.86],7.361895232521948e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,26036,26,4.09 [1.36-12.27],0.012157979393147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,26039,26,4.70 [2.91-7.59],2.3022752456331954e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,25641,25,2.41 [1.67-3.48],2.9900306848819206e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,26036,26,2.95 [1.81-4.80],1.305772042429805e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,25641,25,3.26 [2.29-4.64],5.21926988963756e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,25944,25,4.83 [1.43-16.32],0.0111040340326849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,22510,25,4.37 [2.51-7.63],2.059621833641388e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNNI3,"Troponin I, cardiac muscle",25337,26,1.64 [1.00-2.68],0.048403077198349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,22521,25,1.85 [1.20-2.86],0.005515967517677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP2B,DNA topoisomerase 2-beta,21882,23,1.71 [1.11-2.62],0.0141159826206208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOR1AIP1,Torsin-1A-interacting protein 1,21934,25,1.80 [1.13-2.86],0.0133330527246382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53I3,Quinone oxidoreductase PIG3,21567,23,2.39 [1.21-4.70],0.011913198886344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,25648,25,1.98 [1.10-3.56],0.0220145466888142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPR,Nucleoprotein TPR,21807,24,1.53 [1.00-2.34],0.0498904977320265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC22D1,TSC22 domain family protein 1,22479,24,1.65 [1.12-2.45],0.012237739155028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN1,Tetraspanin-1,25337,26,2.02 [1.09-3.73],0.0249711330777658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN8,Tetraspanin-8,22409,24,1.61 [1.12-2.31],0.0100860805350938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TWF2,Twinfilin-2,22510,25,1.62 [1.04-2.52],0.0327466256978585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXLNA,Alpha-taxilin,25641,25,1.53 [1.01-2.30],0.042764877003169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,26036,26,1.82 [1.13-2.94],0.0144620420212494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",21882,23,2.25 [1.14-4.46],0.0197467466738425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,22521,25,2.12 [1.19-3.77],0.0102469919061632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBXN1,UBX domain-containing protein 1,22039,23,1.92 [1.13-3.27],0.0162388665898223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,25641,25,5.75 [2.94-11.27],3.341593088758171e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,26056,27,0.64 [0.50-0.83],0.0005671554927242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNG,Uracil-DNA glycosylase,22389,25,2.46 [1.21-5.01],0.0129939414763671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROD,Uroporphyrinogen decarboxylase,22039,23,1.95 [1.13-3.39],0.0171536646311537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,22389,25,1.73 [1.03-2.93],0.0399728020404535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,22469,25,2.17 [1.25-3.78],0.0060741148386732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,25337,26,1.45 [1.03-2.03],0.032508693005025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,25854,27,7.21 [2.76-18.84],5.501338747326152e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,25995,26,1.94 [1.15-3.29],0.0136083085500784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,21882,23,9.09 [3.76-21.98],9.523561035821148e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,26035,26,3.45 [1.36-8.70],0.0088907961212846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VGF,Neurosecretory protein VGF,22479,24,7.06 [2.65-18.78],8.975905593559132e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,25691,26,2.15 [1.23-3.76],0.0070532527925539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN2,Vascular non-inflammatory molecule 2,25691,26,2.56 [1.04-6.31],0.041879906038812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,22389,25,2.85 [1.89-4.32],6.970520583270753e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,25774,26,4.62 [2.79-7.66],2.899256685500777e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,25775,27,1.65 [1.04-2.64],0.034375539971112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM1,V-set and transmembrane domain-containing protein 1,25203,25,1.96 [1.09-3.53],0.0254409034110417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,25337,26,1.54 [1.09-2.18],0.014246644979605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA1,von Willebrand factor A domain-containing protein 1,25983,27,2.26 [1.01-5.05],0.0474661568956561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,25553,25,4.31 [1.85-10.08],0.0007369664445815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,25337,26,1.45 [1.01-2.07],0.042166151173425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,21951,25,1.58 [1.16-2.17],0.0042520786540571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC12,WAP four-disulfide core domain protein 12,25991,27,1.73 [1.08-2.78],0.023262477867635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,24486,26,6.49 [4.06-10.39],5.845349575635905e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",25566,25,0.36 [0.16-0.82],0.0152024726325086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,25307,25,3.91 [2.36-6.50],1.349562311900391e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,25995,27,4.75 [3.22-7.00],3.242158325313956e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XIAP,E3 ubiquitin-protein ligase XIAP,21882,23,1.90 [1.03-3.52],0.0402796620654875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,25902,27,0.54 [0.37-0.78],0.0011796437828897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,22469,25,8.57 [5.00-14.70],5.9232039054972685e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,25337,26,2.36 [1.49-3.73],0.0002352840795438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZFYVE19,Abscission/NoCut checkpoint regulator,22409,24,1.62 [1.05-2.50],0.0277066096935263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZHX2,Zinc fingers and homeoboxes protein 2,22469,25,2.04 [1.12-3.72],0.0195992533076687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF174,Zinc finger protein 174,21882,23,2.04 [1.29-3.22],0.0023279745246727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,22409,24,1.74 [1.07-2.82],0.0257550721919614
